Covid-19 roundup: FDA to sign off on Merck, Pfizer pills this week — report; Broad Institute finds rise of Omicron through CRISPR diagnostics
The FDA may soon sign off on two new pills from Merck and Pfizer to help treat Covid-19 before those infected end up in the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
